Documenti di Didattica
Documenti di Professioni
Documenti di Cultura
https://emedicine.medscape.com/article/910770-overview#showall
Pityriasis alba, a common skin disorder in children and young adults, most commonly
between ages 3 and 16 years. [1] It is characterized by the presence of ill-defined, scaly, faintly
erythematous patches. These lesions eventually subside, leaving hypopigmented areas (see
the image below) that then slowly return to normal pigmentation. The term is derived from
the words pityriasis (scaly) and alba (white).
Note the characteristic, ill-defined, hypopigmented macules in this 6-year-old child with
pityriasis alba.
Pityriasis alba lesions often occur on the face, with the cheek being a particularly common
site. [2] Initially, erythema may be conspicuous, and minimal serous crusting of some lesions
may occur. The individual lesions are characterized as follows:
Rounded, oval, or irregular plaques that are red, pink, or skin colored and have fine
lamellar or branny scaling with indistinct margins
Usually 1-4 cm in diameter
Most commonly range in number from 4 or 5 to 20 or more
Found on the face, upper arms, neck, or shoulders; the legs and trunk are less
commonly involved; in approximately one half of all patients, the lesions are limited
to the face [3]
Uncommon variants of pityriasis alba are as follows:
In the extensive variant, lesions are less erythematous, less scaly, more persistent,
asymptomatic, and more frequently seen on the trunk and less often on the face. [6]
Diagnosis
Wood's light examination: May help in determining the presence of vitiligo, which
will glow more brightly and have edges with sharper demarcation
Potassium hydroxide (KOH) stain of a skin scraping: Will be positive if the patient
has tinea versicolor (also called pityriasis versicolor), tinea faciei, or tinea corporis
Skin biopsy: Not usually necessary or particularly helpful in establishing a diagnosis
of pityriasis alba but may be indicated if a diagnosis of mycosis fungoides (cutaneous
T-cell lymphoma) is a significant possibility [7]
Management
Pityriasis alba resolves spontaneously; treatment consists primarily of good general skin care
and education of a young patient’s parents about the benign nature of this self-limited
disorder. Therapy may also include the following:
Low-potency topical steroids (eg, hydrocortisone 1%, desonide 0.05%): May help
with erythema and pruritus associated with the initial lesions and may accelerate
repigmentation of existing lesions; use should be limited, however, to avoid long-term
skin atrophy and steroid changes
Tar paste: May be helpful for chronic lesions on the trunk
Bland emollient cream: Used to reduce the scaling of lesions, especially on the face
Psoralen plus ultraviolet light A (PUVA) photochemotherapy: May be used to help
with repigmentation in extensive cases; recurrence rate is high after treatment is
stopped [8]
Tacrolimus ointment 0.1% and pimecrolimus cream 1%: Have been reported to be
beneficial in the treatment of pityriasis alba [9, 10, 11]
Laser therapy: Treatment with a 308-nm excimer laser twice a week for 12 weeks has
been shown to be effective against pityriasis alba [12]
See Treatment and Medication for more detail.
Background
Pityriasis alba, a relatively common skin disorder in children and young adults, is
characterized by the presence of ill-defined, scaly, faintly erythematous patches. These
lesions eventually subside, leaving hypopigmented areas that then slowly return to normal
pigmentation (see the images below). [1, 13] Lesions may progress through the following three
clinical stages (see Clinical Presentation):
Note the characteristic, ill-defined, hypopigmented macules in this 6-year-old child with
pityriasis alba.
Pityriasis alba.
The duration of pityriasis alba varies from 1 month to 10 years, with most cases resolving
over a period of several months to a year. [2] Diagnosis is made clinically, and treatment
consists of skin care and education of a young patient’s parents about the benign nature of the
disorder. Hydrocortisone may decrease erythema, scaling, and pruritus, if present. (See
Prognosis, Workup, and Treatment.)
Pityriasis alba, although a nonspecific finding, is commonly associated with atopic dermatitis.
The etiology of pityriasis alba is unknown, but xerosis that presents in individuals with atopic
diathesis is an important element in the development of the disease. (See Pathophysiology
and Etiology.)
Debate exists as to the validity of the term extensive pityriasis alba, which some believe to be
a confusing misnomer applied to a pathoetiologically different entity. Some authors believe
that extensive pityriasis alba overlaps with another condition, described as "progressive and
extensive hypomelanosis" in persons of mixed racial background and also reported as
"progressive and confluent hypomelanosis of the melanodermic metis" or "creole
dyschromia.” The alternate name of "progressive extensive hypomelanosis" has been
proposed. [14]
Patient education
Educate the parents about the benign, self-limited nature of pityriasis alba.
Pathophysiology
Pityriasis alba
Ultrastructural studies in patients with pityriasis alba have noted that despite reduced pigment
in lesional skin, there is no difference in melanocytes between lesional and nonlesional skin
in the same patient, although this finding is still under debate. Degenerative changes in
melanocytes and reduced keratonocyte melanosomes have also been noted. [15]
In the same study, the presence of hyperkeratosis and parakeratosis was inconsistent, and
these conditions were thought unlikely to contribute significantly to the pathogenesis of the
hypomelanosis. Various amounts of intercellular edema were found.
Etiology
No known cause of pityriasis alba has been reported. The condition is not contagious, and no
infectious agent has been identified.
Leading theories as to the origin of the lesions in pityriasis alba involve atopy and
postinflammatory changes, with a large number of patients with pityriasis alba having a
history of atopic disease, and atopic patients are being more prone to developing the
condition. [17, 2]
Theories of origin also include hypopigmentation secondary to pityriacitrin, a substance
produced by Malassezia yeasts that acts as a natural sunscreen.
In one study, atrophic sebaceous glands were noted in almost half the cases of pityriasis alba.
In another study, iron deficiency anemia was reported in 16.5% of patients [2] ; this may be a
coincidental finding, however, and the clinical relevance of anemia is not yet known.
Excessively dry skin, which is frequently exacerbated by cold, dry environments, also
appears to be a common factor in pityriasis alba.
Reported contributory factors related to the development of pityriasis alba are excessive and
unprotected sun exposure, poor hygienic habits, and environmental influences such as
temperature, humidity, and altitude. [18, 19] In addition, one study has shown patients with
pityriasis alba were more likely to have low levels of serum copper, possibly contributing to
tyrosinase dysfunction, and therefore a decrease in the production of melanin. [20]
Epidemiology
Occurrence in the United States
Although the exact incidence has not been described, up to 5% of children may have
pityriasis alba. [21] The disorder is not seasonal, but the dry, slightly scaly appearance tends to
worsen during cold months, when the air is relatively dry inside the home. In addition, sun
exposure may make the lesions more obvious during spring and summer. The condition is
more common in patients with a history of atopy.
International occurrence
In a study of 9955 schoolchildren aged 6-16 years who lived in a tropical region, the
prevalence of pityriasis alba was 9.9%. [22, 23] Another study, in Nepal, showed that the
prevalence of pityriasis alba within a wide range of dermatoses was 5.2%. [24]
Pityriasis alba occurs in people of all races. One study found the incidence to be slightly
higher in light-skinned people, while other studies have demonstrated the opposite. The
condition is frequently more apparent and cosmetically bothersome in patients with darker
complexions. [17, 19] Both sexes are equally susceptible to the disease, but a slight male
predominance has been noted. [2, 18]
Pityriasis alba is most common in children aged 3-16 years, with 90% of cases occurring in
children younger than 12 years. The disease occasionally is found in adults. [17]
Prognosis
Pityriasis alba is generally self-limited, and the prognosis is good, with eventual complete
repigmentation. No long-term residual effects are expected.
Cosmetic appearance while the lesions are present may be an issue with some pediatric
patients but is more likely to be of concern to their parents. Risk of sunburn is slightly
increased in areas of hypopigmentation.
The duration of symptoms is different for each patient. Recurrent crops of new lesions may
develop at intervals, with the duration of pityriasis alba varying from 1 month to 10 years.
Usually, however, cases resolve over a period of several months to a year. [2] Treatment may
shorten the duration of the lesions to several weeks in certain cases. (See the image below.)
The hypopigmentation produced by pityriasis alba may take a year or longer to return to
normal.